Research Article

Intramammary ozone therapy in Candida mastitis

Volume: 9 Number: 2 August 31, 2024
EN

Intramammary ozone therapy in Candida mastitis

Abstract

This study investigated the effect of intramammary ozonated distilled water on treatment success rates for mastitis caused by Candida spp., which resulted from intensive antibiotic use. The study material involved 60 Holstein udder quarters infected with Candida spp., which were divided into an ozone treatment group (n=30) and a control group (n=30). To conduct the study, 25 μg/ml of ozonated distilled water was applied intramammary to each udder quarter from which the causative agent had been isolated. Milk samples were collected on days 6 and 18 after application, and microbiological and mycological analyses were performed on them. The analysis results showed no statistically significant difference in recovery rates between days 0-6 after treatment, but a significant difference emerged between days 6-18 (P<0.05). A significant statistical difference also existed in the overall recovery rates between the ozone and control groups (P<0.05). Consequently, the conclusion drawn was that utilizing ozonated distilled water may prove effective for treating mastitis caused by Candida spp. and may increase recovery rates.

Keywords

References

  1. Abd El-Razik, K.A., Abdelrahman, K.A., Abd El-Moez, S., & Danial, E.N. (2011). New approach in diagnosis and treatment of bovine mycotic mastitis in Egypt. African Journal of Microbiology Research, 5(31), 5725-5732. https://doi.org/10.5897/AJMR11.1200
  2. Akdouche, L., Aissi, M., Zeina, S., & Saadi, A. (2014). Importance of yeast in the mammary infection of the cattle in the Region of Sidi M’Hamed Ben Ali, Wilaya of Relizane, Algeria. Journal of Veterinary Science Technology, 5(2), 1-4. https://doi.org/10.5897/JMA2014.0300
  3. Asfour, H.A.E., Eid, R.H., El-Wakeel, S.A., Behour, T.S., & Darwish, S.F. (2021). Phenotypic and genotypic investigation of yeast species associated with bovine subclinical mastitis with a special reference to their virulence characteristics. International Journal of Veterinary Science, 10.47278/journal.ijvs/2021.071
  4. Barasch, A., & Griffin, A.V. (2008). Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials. Future Microbiology,3(3), 265-269. https://doi.org/10.2217/17460913.3.3.265
  5. Bekele, T., Lakew, M., Terefe, G., Koran, T., Olani, A., Yimesgen, L., Tamiru, M., & Demissie, T. (2019). Study on bovine mastitis with isolation of bacterial and fungal causal agents and assessing antimicrobial resistance patterns of isolated Staphylococcus species in and around Sebeta town, Ethiopia. African Journal of Microbiology Research, 13(1), 23-32. https://doi.org/10.5897/AJMR2018.8909
  6. Bourtzi-Hatzopoulou, E., Zdragas, A., Petridou, E., & Filiousis, G. (2003). Yeast as a causative agent of bovine mastitis in Greece. Journal Of The Hellenic Veterinary Medical Society, 54(2), 105-110. https://doi.org/10.12681/jhvms.15257
  7. Cheng, W.N., & Han, S.G. (2020). Bovine mastitis: risk factors, therapeutic strategies, and alternative treatments- A review. Asian-Australasian Journal of Animal Sciences, 33(11), 1699-1713. https://doi.org/10.5713/ajas.20.0156
  8. Costa, E.O., Gandra, C.R., Pires, M.F., Coutinho, S.D., Castilho, W., & Teixeira, C.M. (1993). Survey of bovine mycotic in dairy herds in the State of Sao Paulo, Brazil. Mycopathologia, 124(1), 13-17. https://doi.org/10.1007/BF01103051

Details

Primary Language

English

Subjects

Veterinary Obstetrics and Gynecology

Journal Section

Research Article

Authors

Publication Date

August 31, 2024

Submission Date

May 8, 2024

Acceptance Date

July 12, 2024

Published in Issue

Year 2024 Volume: 9 Number: 2

APA
Köker, A. (2024). Intramammary ozone therapy in Candida mastitis. Mediterranean Veterinary Journal, 9(2), 311-316. https://doi.org/10.24880/meditvetj.1541555
AMA
1.Köker A. Intramammary ozone therapy in Candida mastitis. MeditVetJ. 2024;9(2):311-316. doi:10.24880/meditvetj.1541555
Chicago
Köker, Afşin. 2024. “Intramammary Ozone Therapy in Candida Mastitis”. Mediterranean Veterinary Journal 9 (2): 311-16. https://doi.org/10.24880/meditvetj.1541555.
EndNote
Köker A (August 1, 2024) Intramammary ozone therapy in Candida mastitis. Mediterranean Veterinary Journal 9 2 311–316.
IEEE
[1]A. Köker, “Intramammary ozone therapy in Candida mastitis”, MeditVetJ, vol. 9, no. 2, pp. 311–316, Aug. 2024, doi: 10.24880/meditvetj.1541555.
ISNAD
Köker, Afşin. “Intramammary Ozone Therapy in Candida Mastitis”. Mediterranean Veterinary Journal 9/2 (August 1, 2024): 311-316. https://doi.org/10.24880/meditvetj.1541555.
JAMA
1.Köker A. Intramammary ozone therapy in Candida mastitis. MeditVetJ. 2024;9:311–316.
MLA
Köker, Afşin. “Intramammary Ozone Therapy in Candida Mastitis”. Mediterranean Veterinary Journal, vol. 9, no. 2, Aug. 2024, pp. 311-6, doi:10.24880/meditvetj.1541555.
Vancouver
1.Afşin Köker. Intramammary ozone therapy in Candida mastitis. MeditVetJ. 2024 Aug. 1;9(2):311-6. doi:10.24880/meditvetj.1541555